Syra Financial Statements From 2010 to 2025

Stocks . USA . 
Stock . Syra Health Corp
SYRA Stock  USD 0.10  0.01  9.09%   
Syra Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Syra Health's valuation are provided below:
Gross Profit
2.2 M
Profit Margin
(0.17)
Market Capitalization
1.2 M
Enterprise Value Revenue
0.4951
Revenue
7.5 M
We have found one hundred twenty available fundamental trend indicators for Syra Health Corp, which can be analyzed and compared to other ratios and to its competition. All investors should make sure to double-check all of Syra Health Corp current market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road.

Syra Health Total Revenue

5.64 Million

Check Syra Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Syra Health's main balance sheet or income statement drivers, such as Depreciation And Amortization of 39.1 K, Other Operating Expenses of 6.4 M or Total Operating Expenses of 2.9 M, as well as many indicators such as Price To Sales Ratio of 0.36, Dividend Yield of 0.0 or PTB Ratio of 1.09. Syra financial statements analysis is a perfect complement when working with Syra Health Valuation or Volatility modules.
  
Build AI portfolio with Syra Stock
Check out the analysis of Syra Health Correlation against competitors.

Syra Health Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets2.5 M3.7 M875.9 K
Slightly volatile
Short and Long Term Debt Total435.8 K452.1 K152.9 K
Slightly volatile
Other Current Liabilities160.4 K230.4 K58.2 K
Slightly volatile
Total Current Liabilities776.5 K613.5 K273.6 K
Slightly volatile
Cash1.3 M2.4 M442.7 K
Slightly volatile
Cash And Short Term Investments1.3 M2.4 M442.7 K
Slightly volatile
Common Stock Shares Outstanding7.2 M7.3 M6.2 M
Slightly volatile
Liabilities And Stockholders Equity2.5 M3.7 M875.9 K
Slightly volatile
Total Liabilities851.7 K800.8 K299.7 K
Slightly volatile
Short and Long Term Debt282.8 K152.9 K99.9 K
Slightly volatile
Total Current Assets2.2 M3.4 M760.2 K
Slightly volatile
Capital Stock5 K9.8 K2.4 K
Slightly volatile
Short Term Debt360.5 K264.9 K126.8 K
Slightly volatile
Common Stock5 K9.8 K2.4 K
Slightly volatile
Other Current Assets177.3 K276.6 K66.2 K
Slightly volatile
Other Stockholder Equity6.5 M11.7 M1.9 M
Slightly volatile
Other Assets551100097.7844
Slightly volatile
Current Deferred Revenue13.3 K14.9 K16.3 K
Slightly volatile

Syra Health Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization39.1 K62.7 K45.6 K
Slightly volatile
Other Operating Expenses6.4 M11.7 M2.2 M
Slightly volatile
Total Operating Expenses2.9 M5.4 M1 M
Slightly volatile
Selling General Administrative3.4 M4.8 M1.3 M
Slightly volatile
Selling And Marketing Expenses4 M3.8 M751.8 K
Slightly volatile
Total Revenue5.6 M8 M2.6 M
Slightly volatile
Gross Profit1.3 M1.7 M658.7 K
Slightly volatile
Cost Of Revenue4.4 M6.3 M1.9 M
Slightly volatile
Reconciled Depreciation34.8 K62.7 K10.2 K
Slightly volatile

Syra Health Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Cash From Financing Activities2.3 M2.1 M831.2 K
Slightly volatile
End Period Cash Flow1.3 M2.4 M465.9 K
Slightly volatile
Begin Period Cash Flow3.4 M3.3 M429 K
Slightly volatile
Depreciation34.8 K62.7 K10.2 K
Slightly volatile
Other Non Cash Items185.8 K160.9 K88.4 K
Slightly volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio0.360.374911.9189
Slightly volatile
Days Sales Outstanding29.5831.132568.9363
Slightly volatile
Average Payables402.4 K282.3 K435.9 K
Slightly volatile
Stock Based Compensation To Revenue0.00790.00750.0018
Slightly volatile
Capex To Depreciation0.170.177123.3379
Slightly volatile
EV To Sales0.120.131411.9939
Slightly volatile
Inventory Turnover77.2186.8694.7002
Slightly volatile
Days Of Inventory On Hand3.023.43.7105
Slightly volatile
Payables Turnover65.3562.239315.026
Slightly volatile
Sales General And Administrative To Revenue0.430.59760.3655
Slightly volatile
Average Inventory18.9 K21.2 K23.2 K
Slightly volatile
Research And Ddevelopement To Revenue0.04670.07330.0456
Slightly volatile
Capex To Revenue0.00130.00140.005
Very volatile
Cash Per Share0.350.32970.0857
Slightly volatile
Days Payables Outstanding5.575.864540.6022
Slightly volatile
Income Quality0.740.7820.3874
Slightly volatile
Current Ratio5.745.46461.4269
Slightly volatile
Receivables Turnover12.3111.72415.8022
Slightly volatile
Capex Per Share0.00150.00150.0023
Slightly volatile
Average Receivables592.1 K1.1 M343.9 K
Slightly volatile
Revenue Per Share0.681.09870.387
Slightly volatile
Interest Debt Per Share0.05410.06440.0248
Slightly volatile
Debt To Assets0.120.12290.5225
Slightly volatile
Operating Cycle29.5831.132569.1727
Slightly volatile
Days Of Payables Outstanding5.575.864540.6022
Slightly volatile
Ebt Per Ebit0.950.99858.5563
Slightly volatile
Long Term Debt To Capitalization0.04890.0550.0599
Slightly volatile
Quick Ratio5.745.46461.425
Slightly volatile
Net Income Per E B T0.06660.0750.0818
Slightly volatile
Cash Ratio4.13.90421.0273
Slightly volatile
Cash Conversion Cycle39.8925.26829.5629
Slightly volatile
Days Of Inventory Outstanding3.023.43.7105
Slightly volatile
Days Of Sales Outstanding29.5831.132568.9363
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.131.00381.0656
Pretty Stable
Fixed Asset Turnover18.2724.519713.1156
Slightly volatile
Debt Ratio0.120.12290.5225
Slightly volatile
Price Sales Ratio0.360.374911.9189
Slightly volatile
Asset Turnover2.292.16942.4697
Slightly volatile
Gross Profit Margin0.260.20710.2859
Slightly volatile

Syra Health Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap4.4 M3 M4.8 M
Slightly volatile
Enterprise Value1.6 M1 M1.8 M
Slightly volatile

Syra Fundamental Market Drivers

Syra Upcoming Events

13th of February 2024
Upcoming Quarterly Report
View
31st of December 2023
Next Fiscal Quarter End
View

About Syra Health Financial Statements

Syra Health stakeholders use historical fundamental indicators, such as Syra Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although Syra Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in Syra Health's assets and liabilities are reflected in the revenues and expenses on Syra Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Syra Health Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue14.9 K13.3 K
Total Revenue8 M5.6 M
Cost Of Revenue6.3 M4.4 M
Stock Based Compensation To Revenue 0.01  0.01 
Sales General And Administrative To Revenue 0.60  0.43 
Research And Ddevelopement To Revenue 0.07  0.05 
Revenue Per Share 1.10  0.68 
Ebit Per Revenue(0.47)(0.50)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
DDDupont De Nemours
CRDOCredo Technology Group
GOOGAlphabet Inc Class C
When determining whether Syra Health Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Syra Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Syra Health Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Syra Health Corp Stock:
How To Invest In Syra
Details
Is Syra Stock a good investment?
Details
What is Syra Health's Net Worth?
Details
Largest Health Care Providers & Services Companies
View
Largest Health Care Equipment & Services Companies
View
Check out the analysis of Syra Health Correlation against competitors.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Syra Health. If investors know Syra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Syra Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.08)
Revenue Per Share
0.662
Quarterly Revenue Growth
(0.25)
Return On Assets
(0.21)
Return On Equity
(0.46)
The market value of Syra Health Corp is measured differently than its book value, which is the value of Syra that is recorded on the company's balance sheet. Investors also form their own opinion of Syra Health's value that differs from its market value or its book value, called intrinsic value, which is Syra Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Syra Health's market value can be influenced by many factors that don't directly affect Syra Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Please note, there is a significant difference between Syra Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Syra Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Syra Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2025 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY